Concepedia

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

Matthew R. Moore, Ruth Link‐Gelles, William Schaffner, Ruth Lynfield, Catherine Lexau, Nancy M. Bennett, Susan Petit, Shelley M. Zansky, Lee H. Harrison, Arthur Reingold,

The Lancet Infectious Diseases · 2015 · 730 citations · 29 references

DOIFull text

Open access

Concepts

References

29

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

Tamara Pilishvili, Catherine Lexau, Monica M. Farley et al. · The Journal of Infectious Diseases · 2009 · 1.3K citations · Full text

, , +17

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

American Journal of Transplantation · 2012 · 690 citations · Full text

, , +14

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.

Sara Tomczyk, Nancy M. Bennett, Charles Stoecker et al. · PubMed · 2014 · 677 citations

, , +17

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

Elizabeth Miller, Nicholas J. Andrews, Pauline A. Waight et al. · The Lancet Infectious Diseases · 2011 · 649 citations

, , +17

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

Nick Andrews, Pauline A. Waight, Polly Burbidge et al. · The Lancet Infectious Diseases · 2014 · 545 citations

, , +16